EDIT vs KDP · rev $32.3M vs P/E 23, rev $15.35B
Editas Medicine Inc (EDIT) versus Keurig Dr Pepper Inc (KDP) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Keurig Dr Pepper Inc (KDP) is a beverages - non-alcoholic company listed on NASDAQ.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported KDP revenue for 2024-12-31 was $15.35B. Net income was $1.44B. Revenue was up 3.6% from 2023-12-31 to 2024-12-31. KDP currently screens at market cap $42.03B and trailing P/E 22.9.
EDIT currently screens at market cap $375.2M. KDP currently screens at market cap $42.03B and trailing P/E 22.9.
Not investment advice. Open the EDIT and KDP stock pages for the full models.
Not investment advice.